Third Rock Ventures Joins Founding Investors, MPM Capital and New Enterprise Associates BOSTON, Sept. 8 (HSMN NewsFeed) — Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed it…
Biopharmaceuticals, Venture Capital
Rythm Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Rhythm Closes $40 Million Series A Financing”
Leave a Comment